Alteogen Inc. Logo

Alteogen Inc.

Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):
KR7196170005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시

Description

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-11-29 00:00
[기재정정]회사합병결정(종속회사의주요경영사항)
Korean 20.6 KB
2024-11-29 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 18.3 KB
2024-11-29 00:00
기타주요경영사항(종속회사의주요경영사항) (회사합병결정(종속회사의 주요경영사항)철회 등)
Korean 9.0 KB
2024-11-21 00:00
주식등의대량보유상황보고서(약식)
Korean 58.4 KB
2024-11-21 00:00
풍문또는보도에대한해명(미확정)
Korean 5.3 KB
2024-11-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-18 00:00
주주총회소집결의 (임시주주총회)
Korean 6.3 KB
2024-11-14 00:00
[기재정정]회사합병결정(종속회사의주요경영사항)
Korean 22.7 KB
2024-11-14 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 20.0 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.7 MB
2024-11-08 00:00
투자판단관련주요경영사항 (인간 히알루로니다제 원천 기술(ALT-B4) 독점적 라이선스 계약 체결)
Korean 10.9 KB
2024-11-08 00:00
기업설명회(IR)개최
Korean 6.8 KB
2024-11-07 00:00
회사합병결정(종속회사의주요경영사항)
Korean 18.1 KB
2024-11-07 00:00
타법인주식및출자증권취득결정
Korean 16.5 KB
2024-10-30 00:00
주식등의대량보유상황보고서(약식)
Korean 64.1 KB

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alteogen Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.